FDA Grants Fast Track Designation To Edison Pharma's EPI-743

The U.S. Food and Drug Administration (FDA) has granted Fast Tack designation to Edison Pharmaceuticals’ lead drug EPI-743 for the treatment of Friedreich’s ataxia.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news